| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2026―Jun―06 |
Comparative Effectiveness of mRNA-1273 Versus Protein-Based NVX-CoV2705 Vaccination on COVID-19-Related Outcomes Among Insured Adults in the United States During 2024-2025: A Retrospective Matched Cohort Study |
Amanda Wilson, Ekkehard Beck, Heather Hensler, Nevena Vicic, Keya Joshi, Emily Patry, Linwei Li, Jane Wang, Chris Clarke |
| 2 |
[GO] |
2026―Mar―18 |
Gastrointestinal Symptoms and Abnormal Liver Biochemistry in Patients with COVID-19 Pneumonia Admitted to the Department of Gastroenterology After Ending Zero-COVID Policy in China |
Xiaojie Zheng, Sai Guan, Yuhang Yin, Beilei Zhang, Wen Ning, Wenxiu Zhang, Haonan Zhao, Zhendong Liang, Deli Zou, Xingshun Qi |
| 3 |
[GO] |
2026―Jan―19 |
Correction to: Tiprelestat for Treatment of Hospitalized COVID-19: Results of the Double-Blind Randomized Placebo-Controlled COMCOVID Trial |
Ingmar Bergs, Stephan Budweiser, Hans-Heinrich Henneicke-von Zepelin, Hagen Kelm, Tom Bollmann, Johannes-Josef Tebbe, Stephan Sorichter, Stefan Lüth, Stephan Walterspacher, Henning Wege, Oliver Wiedow, Michael Dreher |
| 4 |
[GO] |
2025―Sep―16 |
Tiprelestat for treatment of hospitalized COVID-19: results of the double-blind randomized placebo-controlled COMCOVID trial |
Ingmar Bergs, Stephan Budweiser, Hans-Heinrich Henneicke-von Zepelin, Hagen Kelm, Tom Bollmann, Johannes-Josef Tebbe, Stephan Sorichter, Stefan Lüth, Stephan Walterspacher, Henning Wege, Oliver Wiedow, Michael Dreher |
| 5 |
[GO] |
2025―Aug―11 |
COVID-19-Related Healthcare Resource Utilisation and Costs in Paediatric Patients in Germany: A Population-Based Study |
Kiran K. Rai, Hannah Gowman, Monica Seif, Lucy Massey, Hannah Volkman, Andrea Schmetz, Jennifer Nguyen, Jingyan Yang |
| 6 |
[GO] |
2025―May―08 |
Therapeutic Approaches for COVID-19: A Review of Antiviral Treatments, Immunotherapies, and Emerging Interventions |
Maria C. S. Alves, Ruana C. C. da Silva, Sérgio S. P. de Leitão-Júnior, Valdir Q. de Balbino |
| 7 |
[GO] |
2025―Mar―10 |
Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Adults with Underlying Medical Conditions: Systematic Literature Review and Pairwise Meta-Analysis Using GRADE |
Xuan Wang, Ankit Pahwa, Mary T. Bausch-Jurken, Anushri Chitkara, Pawana Sharma, Mia Malmenäs, Sonam Vats, Michael Gordon Whitfield, Kira Zhi Hua Lai, Priyadarsini Dasari, Ritu Gupta, Maria Nassim, Nicolas Van de Velde, Nathan Green, Ekkehard Beck |
| 8 |
[GO] |
2025―Feb―10 |
Cost-effectiveness Analysis of COVID-19 mRNA XBB.1.5 Fall 2023 Vaccination in the Netherlands |
Florian Zeevat, Simon van der Pol, Tjalke Westra, Ekkehard Beck, Maarten J. Postma, Cornelis Boersma |
| 9 |
[GO] |
2025―Jan―15 |
Randomised, Placebo-Controlled, Double-Blind Trial to Assess Efficacy and Safety of ELOM-080 in Outpatients with COVID-19 |
Michael Dreher, Hanna-Teresa Heier, Andrea Kienle-Gogolok, Kristina Röschmann-Doose, Jörg Simon, Ravi Singhal, Heidrun Täschner, Jörn Thomsen, Joachim Weimer, Thomas Wittig, Otto Wonhas, Manuela Thinesse-Mallwitz |
| 10 |
[GO] |
2024―Dec―16 |
Is COVID-19 Still a Threat? An Expert Opinion Review on the Continued Healthcare Burden in Immunocompromised Individuals |
Christoph D. Spinner, Samira Bell, Hermann Einsele, Cécile Tremblay, Michel Goldman, Zain Chagla, Axel Finckh, Christopher J. Edwards, Igor Aurer, Odile Launay, Carolina Casañas i Comabella, Samantha James, Sabada Dube, Katarzyna Borkowska, Fungwe Jah, Walid Kandeil, Renata T. C. Yokota, Cécile Artaud, Jacques-Eric Gottenberg, Loreto Gesualdo, Dominique Bertrand, Sofie Arnetorp, Gkikas Magiorkinis |
| 11 |
[GO] |
2024―Jan―13 |
Assessing the Burden and Cost of COVID-19 Across Variants in Commercially Insured Immunocompromised Populations in the United States: Updated Results and Trends from the Ongoing EPOCH-US Study |
Amita Ketkar, Vincent Willey, Lisa Glasser, Casey Dobie, Cachet Wenziger, Chia-Chen Teng, Christine Dube, Sunny Hirpara, Dennis Cunningham, Monica Verduzco-Gutierrez |
| 12 |
[GO] |
2023―Dec―04 |
The Impact of the COVID-19 Pandemic on Patients with Ulcerative Colitis: Results from a Global Ulcerative Colitis Narrative Patient Survey |
Laurent Peyrin-Biroulet, Karoliina Ylänne, Allyson Sipes, Michelle Segovia, Sean Gardiner, Joseph C. Cappelleri, Amy Mulvey, Remo Panaccione |
| 13 |
[GO] |
2023―Nov―27 |
Study Protocol of a Randomized Controlled Clinical Trial to Evaluate the Efficacy and Safety of Ropeginterferon Alfa-2b in COVID-19 Patients with Comorbidities |
Wang-Da Liu, Hsin-An Hou, Ko-Jen Li, Albert Qin, Chan-Yen Tsai, Wang-Huei Sheng |
| 14 |
[GO] |
2023―Aug―24 |
Ramipril for the Treatment of COVID-19: RAMIC, a Randomized, Double-Blind, Placebo-Controlled Clinical Trial |
Daniel Q. Huang, Veeral Ajmera, Christian Tomaszewski, Andrew LaFree, Ricki Bettencourt, Wesley K. Thompson, Davey M. Smith, Atul Malhotra, Ravindra L. Mehta, Vaishal Tolia, Jeffrey Yin, Paul A. Insel, Stone Leachman, Jinho Jung, Summer Collier, Lisa Richards, Kristin Woods, Maral Amangurbanova, Archana Bhatt, Xinlian Zhang, Oana M. Penciu, Stuart Zarich, Tamrat Retta, Michelle S. Harkins, J. Pedro Teixeira, Brian Chinnock, Netanya S. Utay, Jordan E. Lake, Rohit Loomba |
| 15 |
[GO] |
2023―Jul―01 |
Factors That Predict a Sustained Humoral Response to COVID-19 Vaccines in Kidney Transplant Recipients |
Pierre Pommerolle, Pierre Laurent, Claire Presne, François Brazier, Maïté Jaureguy, Coralie Poulain, Gauthier Flahaut, Hakim Mazouz, Etienne Brochot, Gabriel Choukroun, Ophélie Fourdinier |
| 16 |
[GO] |
2023―Jun―22 |
Correction to: A Review of Safety Outcomes from Clinical Trials of Baricitinib in Rheumatology, Dermatology and COVID-19 |
Thomas Bieber, Eugen Feist, Alan D. Irvine, Masayoshi Harigai, Ewa Haladyj, Susan Ball, Walter Deberdt, Maher Issa, Susanne Grond, Peter C. Taylor |
| 17 |
[GO] |
2023―Jun―20 |
Factors Associated with Severe COVID-19 Among Patients with Rheumatoid Arthritis: A Large, Nationwide Electronic Health Record Cohort Study in the United States |
Yizhou Ye, Xiaomeng Yue, Whitney S. Krueger, Lani R. Wegrzyn, Anna W. Maniccia, Kevin L. Winthrop, Seoyoung C. Kim |
| 18 |
[GO] |
2023―Jun―12 |
Estimation of Intangible Costs for Factors Associated with Oral Antiviral Drugs for COVID-19 Treatment: A Conjoint Analysis in Japan |
Naoki Hosogaya, Takahiro Takazono, Kenji Kurazono, Shinzo Hiroi, Kosuke Iwasaki, Tomomi Takeshima, Chise Ha, Hiroshi Mukae |
| 19 |
[GO] |
2022―Sep―25 |
Risk of Severe COVID-19 Outcomes Among Patients with Immune-Mediated Inflammatory Diseases or Malignancies: A Retrospective Analysis of Real-World Data in the United States |
Xiaomeng Yue, Yizhou Ye, Yookyung C. Choi, Dongmu Zhang, Whitney S. Krueger |
| 20 |
[GO] |
2022―Sep―17 |
Experience on the Management of Patients with Asthma or Chronic Obstructive Pulmonary Disease During the COVID-19 Pandemic: the NEUMOBIAL Study |
Pedro Landete, Jose Ignacio Prieto Romo, Fernando Giacomini |
| 21 |
[GO] |
2022―Sep―05 |
A Review of Safety Outcomes from Clinical Trials of Baricitinib in Rheumatology, Dermatology and COVID-19 |
Thomas Bieber, Eugen Feist, Alan D. Irvine, Masayoshi Harigai, Ewa Haladyj, Susan Ball, Walter Deberdt, Maher Issa, Susanne Grond, Peter C. Taylor |
| 22 |
[GO] |
2022―Aug―12 |
Comparative Effectiveness of Dexamethasone in Hospitalized COVID-19 Patients in the United States |
Casey Kar-Chan Choong, Mark Belger, Alisa E. Koch, Kristin J. Meyers, Vincent C. Marconi, Hamed Abedtash, Douglas Faries, Venkatesh Krishnan |
| 23 |
[GO] |
2022―Jun―30 |
Immune Persistence and Safety After SARS-CoV-2 BNT162b1 mRNA Vaccination in Chinese Adults: A Randomized, Placebo-Controlled, Double-Blind Phase 1 Trial |
Jingxin Li, Ai-Min Hui, Xiang Zhang, Lei Ge, Yuanzheng Qiu, Rong Tang, Huayue Ye, Xiyuan Wang, Mei Lin, Zhongkui Zhu, Jianfei Zheng, Jingjun Qiu, Eleni Lagkadinou, Svetlana Shpyro, Orkun Ozhelvaci, Özlem Türeci, Zakaria Khondker, Wanrong Yin, Yoana Shishkova, Siyue Jia, Hongxing Pan, Fuzhong Peng, Zhilong Ma, Zhenggang Wu, Xiling Guo, Yunfeng Shi, Alexander Muik, Uğur Şahin, Li Zhu, Fengcai Zhu |
| 24 |
[GO] |
2022―May―04 |
Changes in Refractive Error Under COVID-19: A 3-Year Follow-up Study |
Xiaoyan Yang, Qian Fan, Yue Zhang, Xiaoqin Chen, Yanglin Jiang, Haohan Zou, Mengdi Li, Lihua Li, Yan Wang |
| 25 |
[GO] |
2022―Apr―13 |
Efficacy and Safety of ELOM-080 as Add-On Therapy in COVID-19 Patients with Acute Respiratory Insufficiency: Exploratory Data from the Prospective Placebo-Controlled COVARI Trial |
Michael Dreher, Christian Grohè, Niels-Ulrik Hartmann, Stephan Kanzler, Karin Kraft, Christoph Sarrazin, Michael Doll, Jens Spiesshöfer, Stephan Steiner, Jochen Wöhrle, Julia Seeger, Kristina Röschmann-Doose, Jörn Thomsen, Thomas Wittig, Nikolaus Marx, Stephan Eisenmann |
| 26 |
[GO] |
2022―Mar―14 |
Correction to: Perspectives on Subcutaneous Infliximab for Rheumatic Diseases and Inflammatory Bowel Disease: Before, During, and After the COVID-19 Era |
Stefan Schreiber, Shomron Ben-Horin, Rieke Alten, René Westhovens, Laurent Peyrin-Biroulet, Silvio Danese, Toshifumi Hibi, Ken Takeuchi, Fernando Magro, Yoorim An, Dong-Hyeon Kim, SangWook Yoon, Walter Reinisch |
| 27 |
[GO] |
2022―Feb―14 |
Primary Care Management of Asthma Exacerbations or Attacks: Impact of the COVID-19 Pandemic |
Monica Fletcher, Thys van der Molen, Warren Lenney, Isabelle Boucot, Bhumika Aggarwal, Emilio Pizzichini |
| 28 |
[GO] |
2022―Feb―12 |
Correction to: The Influence of COVID-19 on the Stability of Patients with Neovascular Age-Related Macular Degeneration with Different Treatment Regimens |
Bo Jiang, Lin Gao, Su Dong, Qingxue Hou, Minghao Sun, Jingjie Zhang, Haotian Yu, Zhongyu Zhang, Dawei Sun |
| 29 |
[GO] |
2022―Jan―24 |
A New Approach to the Management of COVID-19. Antagonists of IL-6: Siltuximab |
Lucinda Villaescusa, Francisco Zaragozá, Irene Gayo-Abeleira, Cristina Zaragozá |
| 30 |
[GO] |
2022―Jan―06 |
Perspectives on Subcutaneous Infliximab for Rheumatic Diseases and Inflammatory Bowel Disease: Before, During, and After the COVID-19 Era |
Stefan Schreiber, Shomron Ben-Horin, Rieke Alten, René Westhovens, Laurent Peyrin-Biroulet, Silvio Danese, Toshifumi Hibi, Ken Takeuchi, Fernando Magro, Yoorim An, Dong-Hyeon Kim, SangWook Yoon, Walter Reinisch |
| 31 |
[GO] |
2021―Dec―15 |
Clinical Experience with Ropeginterferon Alfa-2b in the Off-Label Use for the Treatment of COVID-19 Patients in Taiwan |
Kuan-Yuan Chen, Kang-Yun Lee, Albert Qin, Ching-Shan Luo, Yun-Kai Yeh, Jing-Quan Zheng, Ching-Mei Chen, Chan-Yen Tsai, Sheena Lin, Jason Liao, Yi-Wen Huang, Po-Hao Feng |
| 32 |
[GO] |
2021―Nov―24 |
The Influence of COVID-19 on the Stability of Patients with Neovascular Age-Related Macular Degeneration with Different Treatment Regimens |
Bo Jiang, Lin Gao, Su Dong, Qingxue Hou, Minghao Sun, Jingjie Zhang, Haotian Yu, Zhongyu Zhang, Dawei Sun |
| 33 |
[GO] |
2021―Nov―22 |
Cost-Effectiveness of Combination of Baricitinib and Remdesivir in Hospitalized Patients with COVID-19 in the United States: A Modelling Study |
Kari Kelton, Tim Klein, Dan Murphy, Mark Belger, Erik Hille, Patrick L. McCollam, Theodore Spiro, Russel Burge |
| 34 |
[GO] |
2021―Nov―18 |
Correction to: Vaccine Considerations for Multiple Sclerosis in the COVID-19 Era |
Patricia K. Coyle, Anne Gocke, Megan Vignos, Scott D. Newsome |
| 35 |
[GO] |
2021―Oct―05 |
Inpatient Hospital Costs for COVID-19 Patients in the United States |
Robert L. Ohsfeldt, Casey Kar-Chan Choong, Patrick L. Mc Collam, Hamed Abedtash, Kari A. Kelton, Russel Burge |
| 36 |
[GO] |
2021―Sep―13 |
Healthcare Resource Use in Patients with Immune-Mediated Conditions Treated with Targeted Immunomodulators During COVID-19 Pandemic: A Retrospective Claims Analysis |
Martin Bergman, Christopher D. Saffore, Katherine J. Kim, Pankaj A. Patel, Vishvas Garg, Si Xuan, Haley B. Naik |
| 37 |
[GO] |
2021―Aug―23 |
Experimental and Compassionate Drug Use During the First Wave of the COVID-19 Pandemic: A Retrospective Single-Center Study |
Or Assouline, Eli Ben-Chetrit, Yigal Helviz, Ramzi Kurd, Marc Leone, Sharon Einav |
| 38 |
[GO] |
2021―Aug―11 |
Cost-Effectiveness Analysis of Remdesivir Treatment in COVID-19 Patients Requiring Low-Flow Oxygen Therapy: Payer Perspective in Turkey |
Ergun Oksuz, Simten Malhan, Mustafa Sait Gonen, Zekayi Kutlubay, Yilmaz Keskindemirci, James Jarrett, Toros Sahin, Gokcem Ozcagli, Ahmet Bilgic, Merve Ozlem Bibilik, Fehmi Tabak |
| 39 |
[GO] |
2021―Jul―18 |
Pulmonary Sequelae at 4 Months After COVID-19 Infection: A Single-Centre Experience of a COVID Follow-Up Service |
Rebecca C. Robey, Katie Kemp, Philip Hayton, Dalia Mudawi, Ran Wang, Melanie Greaves, Veronica Yioe, Pilar Rivera-Ortega, Cristina Avram, Nazia Chaudhuri |
| 40 |
[GO] |
2021―Jun―26 |
Endotracheal Application of Ultraviolet A Light in Critically Ill Patients with Severe Acute Respiratory Syndrome Coronavirus 2: A First-in-Human Study |
Ali Rezaie, Gil Y. Melmed, Gabriela Leite, Ruchi Mathur, Will Takakura, Isabel Pedraza, Michael Lewis, Rekha Murthy, George Chaux, Mark Pimentel |
| 41 |
[GO] |
2021―Jun―12 |
Impact of Remdesivir on the Treatment of COVID-19 During the First Wave in Spain |
Alejandro Soriano, Rocío Montejano, José Sanz-Moreno, Juan Carlos Figueira, Santiago Grau, Robert Güerri-Fernández, Antonio Castro-Gómez, Inés Pérez-Román, Álvaro Hidalgo-Vega, Almudena González-Domínguez |
| 42 |
[GO] |
2021―Jun―04 |
Platelet Reactivity and Coagulation Markers in Patients with COVID-19 |
Adriadne J. Bertolin, Talia F. Dalçóquio, Rocío Salsoso, Remo H. de M. Furtado, Roberto Kalil-Filho, Ludhmila A. Hajjar, Rinaldo F. Siciliano, Esper G. Kallás, Luciano M. Baracioli, Felipe G. Lima, Roberto R. Giraldez, Cyrillo Cavalheiro-Filho, Alexandra Vieira, Célia M. C. Strunz, Robert P. Giugliano, Udaya S. Tantry, Paul A. Gurbel, José C. Nicolau |
| 43 |
[GO] |
2021―Jun―01 |
Vaccine Considerations for Multiple Sclerosis in the COVID-19 Era |
Patricia K. Coyle, Anne Gocke, Megan Vignos, Scott D. Newsome |
| 44 |
[GO] |
2021―May―07 |
A Retrospective Study of COVID-19-Related Urgent Medical Visits and Hospitalizations After Outpatient COVID-19 Diagnosis in the US |
Wenhui Wei, Sumathi Sivapalasingam, Scott Mellis, Gregory P. Geba, Jessica J. Jalbert |
| 45 |
[GO] |
2021―Apr―14 |
Can Thoracic Ultrasound on Admission Predict the Outcome of Critically Ill Patients with SARS-CoV-2? A French Multi-Centric Ancillary Retrospective Study |
Gary Duclos, Florian Bazalguette, Bernard Allaouchiche, Neyla Mohammedi, Alexandre Lopez, Mathieu Gazon, Guillaume Besch, Lionel Bouvet, Laurent Muller, Gauthier Mathon, Charlotte Arbelot, Mohamed Boucekine, Marc Leone, Laurent Zieleskiewicz |
| 46 |
[GO] |
2021―Apr―01 |
Mortality in Patients with COVID-19 on Renin Angiotensin System Inhibitor Long-Term Treatment: An Observational Study Showing that Things Are Not Always as They Seem |
Massimo Cugno, Roberta Gualtierotti, Giovanni Casazza, Francesco Tafuri, Gabriele Ghigliazza, Adriana Torri, Giorgio Costantino, Nicola Montano, Flora Peyvandi |
| 47 |
[GO] |
2021―Mar―01 |
A Cost-Effectiveness Framework for COVID-19 Treatments for Hospitalized Patients in the United States |
Daniel Sheinson, Joseph Dang, Anuj Shah, Yang Meng, David Elsea, Stacey Kowal |
| 48 |
[GO] |
2021―Jan―18 |
Post Abortion Care and Management After Induced Abortion During the COVID-19 Pandemic: A Chinese Expert Consensus |
Yu Wang, Qing Yang |
| 49 |
[GO] |
2020―Dec―26 |
Estimated Impact of Public and Private Sector COVID-19 Diagnostics and Treatments on US Healthcare Resource Utilization |
Daniel M. Sheinson, William B. Wong, Caroline E. Solon, Mindy M. Cheng, Anuj Shah, David Elsea, Yang Meng |
| 50 |
[GO] |
2020―Oct―27 |
Design and Rationale of a Randomized, Double-Blind, Placebo-Controlled, Phase 2/3 Study Evaluating Dociparstat in Acute Lung Injury Associated with Severe COVID-19 |
Joseph A. Lasky, Jyotsna Fuloria, Marion E. Morrison, Randall Lanier, Odin Naderer, Tom Brundage, Allen Melemed |
| 51 |
[GO] |
2020―Oct―12 |
Baseline Demographics and Clinical Characteristics Among 3471 US Patients Hospitalized with COVID-19 and Pulmonary Involvement: A Retrospective Study |
Jennie H. Best, Shalini V. Mohan, Amanda M. Kong, Krish Patel, John M. Pagel, Boris Ivanov, Otis W. Brawley, Krutika Jariwala-Parikh, James L. Zazzali, John Pauk |
| 52 |
[GO] |
2020―Aug―27 |
Preparing the Burns Unit to Accommodate Vaginal Delivery and Cesarean Section for Pregnant Women with COVID-19: A Successful Experience from Jordan |
Omar Altal, Diab Bani Hani, Abdelwahab Aleshawi, Ala”a Alhowary, Basil Obeidat, Majid Bani-Ata |
| 53 |
[GO] |
2020―Aug―18 |
Novel Insights into the Transmission of SARS-CoV-2 Through the Ocular Surface and its Detection in Tears and Conjunctival Secretions: A Review |
Noemi Güemes-Villahoz, Barbara Burgos-Blasco, Beatriz Vidal-Villegas, Julián Garcia-Feijoo, Pedro Arriola-Villalobos, Jose María Martínez-de-la-Casa, David Diaz-Valle, Anastasios G. Konstas |
| 54 |
[GO] |
2020―Aug―18 |
Perspectives on the Early Quality of Evidence Guiding the Therapeutic Management of SARS-CoV-2: A Systematic Literature Review |
Kaushik Subramanian, Anuradha Nalli, Vinitha Senthil, Saurabh Jain, Aravind Nayak, Amit Bhat |
| 55 |
[GO] |
2020―Jul―06 |
Challenging Issues in the Management of Cardiovascular Risk Factors in Diabetes During the COVID-19 Pandemic: A Review of Current Literature |
Leili Rahimi, Mojtaba Malek, Faramarz Ismail-Beigi, Mohammad E. Khamseh |
| 56 |
[GO] |
2020―Jun―05 |
Dysfunctional Coagulation in COVID-19: From Cell to Bedside |
Jie Wang, Ardan M. Saguner, Jiaqi An, Yuye Ning, Yang Yan, Guoliang Li |
| 57 |
[GO] |
2020―Apr―29 |
Anti COVID-19 Drugs: Need for More Clinical Evidence and Global Action |
Zakir Khan, Yusuf Karataş, Hazir Rahman |
| 58 |
[GO] |
2020―Apr―01 |
Warning Against the Use of Anti-Inflammatory Medicines to Cure COVID-19: Building Castles in the Air |
Giustino Varrassi |
|
